EGFR and melanoma: Several pathways previously involved in resistance to BRAFi and/or regulation of melanoma growth and progression were found to be enriched, including MAP kinase-, PI3K/AKT-, ErbB-, Hippo-, WNT-, focal adhesion- and a large series of metabolism-related signaling pathways (Figure 1B).